Chemotherapy-Induced Nausea and Vomiting Drugs Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Chemotherapy-Induced Nausea and Vomiting Drugs in global, including the following market information:
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chemotherapy-Induced Nausea and Vomiting Drugs companies in 2021 (%)
The global Chemotherapy-Induced Nausea and Vomiting Drugs market was valued at 2501 million in 2021 and is projected to reach US$ 3351.1 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Existing Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs include Merck & Co., Inc., GlaxoSmithKline plc, Tesaro, Inc., Helsinn Group, F. Hoffmann-La Roche Ltd., Heron Therapeutics, Inc., Dr. Reddy's Laboratories Ltd., Acacia Pharma and Sun Pharmaceutical Industry Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chemotherapy-Induced Nausea and Vomiting Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, by Type, 2021 (%)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, by Application, 2021 (%)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs revenues share in global market, 2021 (%)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chemotherapy-Induced Nausea and Vomiting Drugs companies in 2021 (%)
The global Chemotherapy-Induced Nausea and Vomiting Drugs market was valued at 2501 million in 2021 and is projected to reach US$ 3351.1 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Existing Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs include Merck & Co., Inc., GlaxoSmithKline plc, Tesaro, Inc., Helsinn Group, F. Hoffmann-La Roche Ltd., Heron Therapeutics, Inc., Dr. Reddy's Laboratories Ltd., Acacia Pharma and Sun Pharmaceutical Industry Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chemotherapy-Induced Nausea and Vomiting Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, by Type, 2021 (%)
- Existing Drugs
- Akynzeo (Netupitant-Palonosetron FDC)
- Aloxi (Palonosetron)
- Emend (Aprepitant)
- Kytril Generic (Granisetron)
- Zofran Generic (Ondansetron)
- Pipeline Drugs
- SUSTOL (Granisetron Injection extended release)
- Rolapitant
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, by Application, 2021 (%)
- Serotonin Receptor Antagonists
- NK1 Receptor Antagonists
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs revenues share in global market, 2021 (%)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Tesaro, Inc.
- Helsinn Group
- F. Hoffmann-La Roche Ltd.
- Heron Therapeutics, Inc.
- Dr. Reddy's Laboratories Ltd.
- Acacia Pharma
- Sun Pharmaceutical Industry Ltd.
- Otsuka Holdings Co., Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS OVERALL MARKET SIZE
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2021 VS 2028
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.2 Top Global Chemotherapy-Induced Nausea and Vomiting Drugs Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies
3.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies
3.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chemotherapy-Induced Nausea and Vomiting Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Markets, 2021 & 2028
4.1.2 Existing Drugs
4.1.3 Akynzeo (Netupitant-Palonosetron FDC)
4.1.4 Aloxi (Palonosetron)
4.1.5 Emend (Aprepitant)
4.1.6 Kytril Generic (Granisetron)
4.1.7 Zofran Generic (Ondansetron)
4.1.8 Pipeline Drugs
4.1.9 SUSTOL (Granisetron Injection extended release)
4.1.10 Rolapitant
4.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2022
4.2.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2023-2028
4.2.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
4.3.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2022
4.3.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2023-2028
4.3.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2021 & 2028
5.1.2 Serotonin Receptor Antagonists
5.1.3 NK1 Receptor Antagonists
5.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2022
5.2.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2023-2028
5.2.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
5.3.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2022
5.3.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2023-2028
5.3.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2021 & 2028
6.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2022
6.2.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2023-2028
6.2.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
6.3.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2022
6.3.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2023-2028
6.3.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.4.2 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.4.3 US Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.4.4 Canada Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.4.5 Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.5.3 Germany Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.4 France Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.5 U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.6 Italy Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.7 Russia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.9 Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.6.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6.4 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6.5 South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6.7 India Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.7.2 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.7.3 Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.7.4 Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.8.3 Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.8.4 Israel Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.8.6 UAE Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Corporate Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Merck & Co., Inc. Key News
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Corporate Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline plc Key News
7.3 Tesaro, Inc.
7.3.1 Tesaro, Inc. Corporate Summary
7.3.2 Tesaro, Inc. Business Overview
7.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Tesaro, Inc. Key News
7.4 Helsinn Group
7.4.1 Helsinn Group Corporate Summary
7.4.2 Helsinn Group Business Overview
7.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Helsinn Group Key News
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.5.5 F. Hoffmann-La Roche Ltd. Key News
7.6 Heron Therapeutics, Inc.
7.6.1 Heron Therapeutics, Inc. Corporate Summary
7.6.2 Heron Therapeutics, Inc. Business Overview
7.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Heron Therapeutics, Inc. Key News
7.7 Dr. Reddy's Laboratories Ltd.
7.7.1 Dr. Reddy's Laboratories Ltd. Corporate Summary
7.7.2 Dr. Reddy's Laboratories Ltd. Business Overview
7.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Dr. Reddy's Laboratories Ltd. Key News
7.8 Acacia Pharma
7.8.1 Acacia Pharma Corporate Summary
7.8.2 Acacia Pharma Business Overview
7.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Acacia Pharma Key News
7.9 Sun Pharmaceutical Industry Ltd.
7.9.1 Sun Pharmaceutical Industry Ltd. Corporate Summary
7.9.2 Sun Pharmaceutical Industry Ltd. Business Overview
7.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Sun Pharmaceutical Industry Ltd. Key News
7.10 Otsuka Holdings Co., Ltd.
7.10.1 Otsuka Holdings Co., Ltd. Corporate Summary
7.10.2 Otsuka Holdings Co., Ltd. Business Overview
7.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Otsuka Holdings Co., Ltd. Key News
8 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, 2017-2028
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS SUPPLY CHAIN ANALYSIS
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Upstream Market
10.3 Chemotherapy-Induced Nausea and Vomiting Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS OVERALL MARKET SIZE
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2021 VS 2028
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.2 Top Global Chemotherapy-Induced Nausea and Vomiting Drugs Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies
3.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies
3.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chemotherapy-Induced Nausea and Vomiting Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Markets, 2021 & 2028
4.1.2 Existing Drugs
4.1.3 Akynzeo (Netupitant-Palonosetron FDC)
4.1.4 Aloxi (Palonosetron)
4.1.5 Emend (Aprepitant)
4.1.6 Kytril Generic (Granisetron)
4.1.7 Zofran Generic (Ondansetron)
4.1.8 Pipeline Drugs
4.1.9 SUSTOL (Granisetron Injection extended release)
4.1.10 Rolapitant
4.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2022
4.2.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2023-2028
4.2.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
4.3.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2022
4.3.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2023-2028
4.3.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2021 & 2028
5.1.2 Serotonin Receptor Antagonists
5.1.3 NK1 Receptor Antagonists
5.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2022
5.2.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2023-2028
5.2.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
5.3.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2022
5.3.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2023-2028
5.3.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2021 & 2028
6.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2022
6.2.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2023-2028
6.2.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
6.3.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2022
6.3.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2023-2028
6.3.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.4.2 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.4.3 US Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.4.4 Canada Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.4.5 Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.5.3 Germany Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.4 France Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.5 U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.6 Italy Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.7 Russia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.5.9 Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.6.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6.4 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6.5 South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.6.7 India Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.7.2 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.7.3 Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.7.4 Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2017-2028
6.8.3 Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.8.4 Israel Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
6.8.6 UAE Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Corporate Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Merck & Co., Inc. Key News
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Corporate Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline plc Key News
7.3 Tesaro, Inc.
7.3.1 Tesaro, Inc. Corporate Summary
7.3.2 Tesaro, Inc. Business Overview
7.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Tesaro, Inc. Key News
7.4 Helsinn Group
7.4.1 Helsinn Group Corporate Summary
7.4.2 Helsinn Group Business Overview
7.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Helsinn Group Key News
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.5.5 F. Hoffmann-La Roche Ltd. Key News
7.6 Heron Therapeutics, Inc.
7.6.1 Heron Therapeutics, Inc. Corporate Summary
7.6.2 Heron Therapeutics, Inc. Business Overview
7.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Heron Therapeutics, Inc. Key News
7.7 Dr. Reddy's Laboratories Ltd.
7.7.1 Dr. Reddy's Laboratories Ltd. Corporate Summary
7.7.2 Dr. Reddy's Laboratories Ltd. Business Overview
7.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Dr. Reddy's Laboratories Ltd. Key News
7.8 Acacia Pharma
7.8.1 Acacia Pharma Corporate Summary
7.8.2 Acacia Pharma Business Overview
7.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Acacia Pharma Key News
7.9 Sun Pharmaceutical Industry Ltd.
7.9.1 Sun Pharmaceutical Industry Ltd. Corporate Summary
7.9.2 Sun Pharmaceutical Industry Ltd. Business Overview
7.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Sun Pharmaceutical Industry Ltd. Key News
7.10 Otsuka Holdings Co., Ltd.
7.10.1 Otsuka Holdings Co., Ltd. Corporate Summary
7.10.2 Otsuka Holdings Co., Ltd. Business Overview
7.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Otsuka Holdings Co., Ltd. Key News
8 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, 2017-2028
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS SUPPLY CHAIN ANALYSIS
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Upstream Market
10.3 Chemotherapy-Induced Nausea and Vomiting Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Chemotherapy-Induced Nausea and Vomiting Drugs in Global Market
Table 2. Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
Table 9. List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 46. Merck & Co., Inc. Corporate Summary
Table 47. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 48. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GlaxoSmithKline plc Corporate Summary
Table 50. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 51. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Tesaro, Inc. Corporate Summary
Table 53. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 54. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Helsinn Group Corporate Summary
Table 56. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 57. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 59. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 60. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Heron Therapeutics, Inc. Corporate Summary
Table 62. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 63. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Dr. Reddy's Laboratories Ltd. Corporate Summary
Table 65. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 66. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Acacia Pharma Corporate Summary
Table 68. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 69. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Sun Pharmaceutical Industry Ltd. Corporate Summary
Table 71. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 72. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Otsuka Holdings Co., Ltd. Corporate Summary
Table 74. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 75. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Chemotherapy-Induced Nausea and Vomiting Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region, 2017-2022 (K Units)
Table 79. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region, 2023-2028 (K Units)
Table 80. Chemotherapy-Induced Nausea and Vomiting Drugs Market Opportunities & Trends in Global Market
Table 81. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers in Global Market
Table 82. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints in Global Market
Table 83. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Materials
Table 84. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Chemotherapy-Induced Nausea and Vomiting Drugs Downstream
Table 86. Chemotherapy-Induced Nausea and Vomiting Drugs Downstream Clients in Global Market
Table 87. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of Chemotherapy-Induced Nausea and Vomiting Drugs in Global Market
Table 2. Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
Table 9. List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2023-2028
Table 46. Merck & Co., Inc. Corporate Summary
Table 47. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 48. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GlaxoSmithKline plc Corporate Summary
Table 50. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 51. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Tesaro, Inc. Corporate Summary
Table 53. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 54. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Helsinn Group Corporate Summary
Table 56. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 57. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 59. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 60. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Heron Therapeutics, Inc. Corporate Summary
Table 62. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 63. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Dr. Reddy's Laboratories Ltd. Corporate Summary
Table 65. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 66. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Acacia Pharma Corporate Summary
Table 68. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 69. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Sun Pharmaceutical Industry Ltd. Corporate Summary
Table 71. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 72. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Otsuka Holdings Co., Ltd. Corporate Summary
Table 74. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 75. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Chemotherapy-Induced Nausea and Vomiting Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region, 2017-2022 (K Units)
Table 79. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region, 2023-2028 (K Units)
Table 80. Chemotherapy-Induced Nausea and Vomiting Drugs Market Opportunities & Trends in Global Market
Table 81. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers in Global Market
Table 82. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints in Global Market
Table 83. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Materials
Table 84. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Chemotherapy-Induced Nausea and Vomiting Drugs Downstream
Table 86. Chemotherapy-Induced Nausea and Vomiting Drugs Downstream Clients in Global Market
Table 87. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
Figure 2. Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
Figure 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting Drugs Revenue in 2021
Figure 9. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 19. US Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 24. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 33. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Chemotherapy-Induced Nausea and Vomiting Drugs by Region, 2020 VS 2027
Figure 50. Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
Figure 2. Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
Figure 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting Drugs Revenue in 2021
Figure 9. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 19. US Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 24. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 33. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Chemotherapy-Induced Nausea and Vomiting Drugs by Region, 2020 VS 2027
Figure 50. Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
Figure 51. Marketing Channels
